¶1This is a federal securities class action brought on behalf of investors against Trevena, Inc. and its former executives for violations of §§ 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995 ("PSLRA"), 15 U.S.C. §§ 78j(b) and 78t(a), and Rule 10b-5 promulgated thereunder, *41117 C.F.R. § 240.10b-5.
¶2I. BACKGROUND
¶3Trevena is a clinical stage biopharmaceutical company that discovers, develops, and seeks to commercialize therapeutics by utilizing a novel approach to treating moderate to severe acute pain intravenously. Trevena allegedly issued a press release on May 2, 2016, announcing that it had reached a general agreement with the FDA on key elements of its clinical development program for one of its products, Olinvo (oliceridine). Based on those statements and omissions as to the strength of the program, the design of its Phase III trial, and its prospects for obtaining FDA approval, the price of Trevena's stock began to increase. On October 9, 2018, however, two days before the FDA would meet with Trevena to determine whether Olinvo would be granted approval, the FDA publicized a briefing document which contained minutes from its 2016 meeting with Trevena that it previously criticized the design of the Phase III trial and that the FDA's Advisory Committee was recommending rejection of Olinvo's new drug application. As a result, the price of Trevena's stock dropped 64% by the time the market closed on October 9. Plaintiffs are comprised of investors who purchased Trevena common stock between May 2, 2016 and October 8, 2018 (the "Class Period").
¶4The Court has previously consolidated the three separate lawsuits against Trevena and its former executives, and now must decide whether Erenoglu, Trevena Group, or Ping will serve as lead plaintiff. A hearing was held on February 20, 2019, after which the Court required Erenoglu to produce his trade confirmations from the Class Period to the Court and to the other Moving Plaintiffs, and permitted further briefing upon receipt of the trade confirmations.
¶5II. PROCEDURAL REQUIREMENTS
¶6The PSLRA requires that within 20 days of filing a complaint, the plaintiff must "cause to be published, in a widely circulated national business-oriented publication or wire service," notice to members of the purported class as to "the pendency of the action, the claims asserted therein, and the purported class period."
¶7On October 11, 2018, one day after the Complaint was filed, a notice of the pendency of this action was published on PR Newswire , a national business-oriented newswire service.
¶8III. LEGAL STANDARD
¶9Under the PSLRA, the court must appoint a lead plaintiff "as soon as practicable" after a class action securities lawsuit has been consolidated.
¶10The presumption "may be rebutted only upon proof by a member of the purported plaintiff class that the presumptively most adequate plaintiff" either: (1) "will not fairly and adequately protect the interests of the class"; or (2) "is subject to unique defenses that render such plaintiff incapable of adequately representing the class."
¶11IV. DISCUSSION
¶12A. Largest Financial Loss
¶13The three relevant factors when analyzing the largest financial interest are: (1) the number of shares purchased during the class period; (2) the total net funds expended by the plaintiffs during the class period; and (3) the approximate losses suffered by the plaintiffs.
¶14Erenoglu alleges that he suffered the greatest financial loss of $ 552,075.43.
¶16Typicality is not a concern here, as all Moving Plaintiffs have established that their claims "arise[ ] from the same event or practice or course of conduct that gives rise to the claims of other class members, and [ ] is based on the same legal theory."
¶171. Huseyin Erenoglu
¶18As the investor with the largest financial loss, Huseyin Erenoglu asserts that his similar interests with those of the class in recovering a maximum amount of damages, his lack of conflict in his adequacy to represent the class, and his choice of counsel *414render him the prevailing lead plaintiff. Erenoglu has submitted a declaration stating that he resides in the United States, independently seeks appointment as lead plaintiff, and understands the requirements to serve as lead plaintiff and is willing to do so.
¶19The other Moving Plaintiffs argue that there are errors in Erenoglu's sworn certifications and declarations when compared to his trade confirmations, and that although Erenoglu's certification and declaration accurately reflect the number of shares purchased and sold, they do not accurately reflect the number of trades and the price per share. Instead, as Erenoglu admits, he combined certain trades and averaged the per-share prices, overstating his total losses by $ 518.61.
¶20The Court agrees with the other Moving Plaintiffs that the errors in Erenoglu's sworn statements amount to a substantial degree of carelessness and raise doubt as to whether he will fairly and adequately represent the best interests of the class. Sworn declarations are integral to the PSLRA process, as they assure district courts that the proposed plaintiff (1) has suffered financial harm; (2) is not a serial litigant; and (3) is interested and able to serve as lead plaintiff.
¶212. Trevena Group
¶22Trevena Group comprises five individuals who lost a substantial amount of monetary funds, and who have indicated a willingness to serve the role of lead plaintiff. Because the PSLRA expressly permits groups to serve as lead plaintiff,
¶23The other Moving Plaintiffs attempt to rebut Trevena Group's presumptive lead plaintiff status by contending that the group is too large, and that the lack of knowledge as to its members' pre-existing relationships raises doubt in terms of whether Trevena Group is lawyer-driven or whether its members can function cohesively and collectively as a group. The Third Circuit has indeed cautioned groups from forming based on efforts of lawyers who hope to "ensure their eventual appointment as lead counsel," and has noted that groups may sometimes be too large for its members to operate effectively as a single unit.
¶24The Third Circuit has agreed "with the Securities and Exchange Commission that courts should generally presume that groups with more than five members are too large to work effectively."
¶25Additionally, even though the other Moving Plaintiffs speculate as to whether this geographically diverse group
¶26The members of Trevena Group submitted a joint declaration stating that they participated in an extensive telephone conference several days before determining that they would jointly move to become lead plaintiff.
¶27C. Appointment of Lead Counsel
¶28The PSLRA vests authority in the lead plaintiff to select and retain counsel, subject to the approval of the court.
¶29Having reviewed the submissions from Trevena Group as to its selection of Block & Leviton LLP as its choice of lead counsel and Kaufman Coren & Ress, P.C. as liaison counsel, the Court finds that there is no basis to interfere with the strong presumption in favor of approving counsel.
¶30V. CONCLUSION
¶31For the foregoing reasons, Trevena Group shall be appointed as lead plaintiff for the class and its selection of Block & Leviton LLP as its choice of lead counsel and Kaufman Coren & Ress, P.C. as liaison counsel is approved. An appropriate order follows.
¶32The cases which have been consolidated in this action are: Tomaszewski v. Trevena, Inc., et al. , No. 18-4378; Mastopietro v. Trevena, Inc., et al. , No. 18-4426; and Louis v. Trevena, Inc., et al. , No. 18-4779. [Doc. No. 18].
¶33Those individual members are Albert Koch, Whittier Pierce, Christopher Beyers, Kevin Walsh and Peter Palmer.
¶34All other individuals or groups who previously moved to be appointed have since withdrawn their motions.
¶35The following facts, unless otherwise noted, are taken from the Complaint and assumed to be true for purposes of the motions.
¶36Order [Doc. No. 35].
¶39See Trevena Group Mot., Ex. A [Doc. No. 8-3] (providing the website's announcement and validating that it was in fact published on October 11, 2018).
¶40Lanphie Ping Mot. [Doc. No. 5]; Trevena Group Mot. [Doc. No. 8]; Huseyin Erenoglu Mot. [Doc. No. 9].
¶4215 U.S.C. §§ 78u-4(a)(3)(B)(iii)(I)(bb)-(cc). As various district courts have noted, the statute was enacted to "prevent 'lawyer-driven' litigation, and to ensure that 'parties with significant holdings in issuers, whose interests are more strongly aligned with the class of shareholders, will participate in the litigation and exercise control over the selection and actions of plaintiffs' counsel.' " Galmi v. Teva Pharm. Indus. Ltd. , 302 F.Supp.3d 485, 492-93 (D. Conn. 2017) (quoting Topping v. Deloitte Touche Tohmatsu CPA , 95 F.Supp.3d 607, 615 (S.D.N.Y. 2015) ); Rabin v. John Doe Market Makers , 254 F.Supp.3d 754, 760 (E.D. Pa. 2015) (citation omitted).
¶44In re Cendant Corp. Litig. , 264 F.3d 201, 267 (3d Cir. 2001) (citation omitted).
¶46SeeKanefsky v. Honeywell Int'l Inc. , No. 18-15536, 2019 WL 936662, at *1 (D.N.J. Feb. 26, 2019) (collecting cases); In re Vicuron Pharm., Inc. Sec. Litig. , 225 F.R.D. 508, 511 (E.D. Pa. 2004) (same).
¶47Huseyin Erenoglu Mot. [Doc. No. 9-1] at 6; Daniel Sadeh Decl. [Doc. No. 9-2] at 2; Huseyin Erenoglu Decl., Ex. C. [Doc. No. 9-5].
¶48SeeIn re Cendant Corp. Litig. , 264 F.3d at 262 ("Any time the question [of the largest financial interest] appears genuinely contestable, we think that a district court would be well within its discretion...in seeking further information if it deems the original submissions to be an inadequate basis for an informed decision.").
¶49In their supplemental briefs, Trevena Group and Ping now appear to concede this point. Lanphie Ping Statement [Doc. No. 39] at 2; Trevena Group Mem. in Further Supp. of Mot. [Doc. No. 40] at 2-3.
¶50Trevena Group Mot. [Doc. No. 8-1] at 6; Deborah Gross Decl., Exs. G-L [Doc. Nos. 8-9 to 8-14].
¶51Lanphie Ping Mot. [Doc. No. 5-1] at 4; Jacob Goldberg Decl., Ex. 3 [Doc. No. 5-5].
¶52Baby Neal v. Casey , 43 F.3d 48, 58 (3d Cir. 1994) (internal quotation marks and citations omitted). The requirement "is designed to align the interests of the class and the class representatives so that the latter will work to benefit the entire class through the pursuit of their own goals." In re Warfarin Sodium Antitrust Litig. , 391 F.3d 516, 531 (3d Cir. 2004) (internal quotation marks and citation omitted). No Moving Plaintiff has attempted to rebut the presumption of another based on issues of typicality.
¶53In re Cedent Corp. Litig. , 264 F.3d at 265 (internal quotation marks and citations omitted).
¶55Huseyin Erenoglu Reply Mem. of Law in Further Supp. of Mot. [Doc. No. 17] at 8; Huseyin Erenoglu Decl. [Doc. No. 17-5] at 1.
¶56See Erenoglu Resp. in Further Supp. of Mot. [Doc. No. 43] at 5 ("The cost basis per share for Mr. Erenoglu's 315,000 share purchase, without the negligible rounding to $ 2.60 per share reflected on his screenshots, is $ 2.5983 per share, which amounts to an approximate $ 500 difference in [ ] total losses.").
¶57Seeid. at 3 n.1 (stating that "there was a minor typographical error relating to the date on which three of those purchases were made," where he "purchased 9,457 shares at $ 2.40 per share in a pre-market trade on October 2, 2018, and he purchased 5 shares at $ 2.69 per share, 15,000 shares at $ 2.70 per share, and 464 shares at $ 2.88 per share on October 4, 2018 instead of October 2, 2018"). Erenoglu also provides that this misstatement was a "minor and inadvertent typographical error" since the actual date was still within the Class Period. Huseyin Erenoglu Reply Mem. of Law in Further Supp. of Mot. [Doc. No. 17] at 1. Furthermore, Erenoglu notes that he will submit a corrected certification with the filing of an anticipated Consolidated Amended Complaint. Id. at 5 n.4 (citing Vladimir v. Bioenvision, Inc. , No. 07-6416, 2007 WL 4526532, at *9 n.19 (S.D.N.Y. Dec. 21, 2007) (accepting revised certifications after typographical and other errors were detected)).
¶59SeeIn re Solar City Corp. Sec. Litig. , No. 16-4686, 2017 WL 363274, at *6 (N.D. Cal. Jan. 25, 2017) ("Multiple district courts have held that minor or inadvertent mistakes made in a sworn certification do not strike at the heart of Rule 23's adequacy requirement." (internal quotation marks and citations omitted)).
¶60SeeCamp v. Qualcomm Inc. , No. 18-1208, 2019 WL 277360, at *3-4 (S.D. Cal. Jan. 22, 2019) (highlighting "doubts about [the lead plaintiff's] ability to serve as the class representative because of ... errors in the transaction records and loss calculations accompanying [his] motion" (internal quotations and citation omitted)); Garbowski v. Tokai Pharmaceuticals, Inc. , 302 F. Supp. 3d 441, 455 (D. Mass. 2018) ("[Plaintiff's] willingness to make false statements under oath contributes to the court's conclusion that he would not have been an adequate lead plaintiff."); Hirtenstein v. Cempra, Inc. , Nos. 16-1356, 16-1451, 2017 WL 2874588, at *3 n.5 (M.D.N.C. July 5, 2017) ("Finally, though the error in [one of the lead plaintiff's] personal declaration[s] did not affect the ... Group's loss calculations, the parties are cautioned that exhibits to sworn declarations should be treated carefully and that even typographical errors can have detrimental effects in securities litigation." (citation omitted)); Bhojwani v. Pistolis , No. 06-13761, 2007 WL 9228588, at *3 (S.D.N.Y. July 31, 2007) (expressing concern with a minor loss calculation error as reflecting "a certain carelessness about detail that undermines the adequacy of" the proposed lead plaintiff).
¶62In re Cendant Corp. Litig. , 264 F.3d at 266-67.
¶63See generally Trevena Group Joint Decl. in Supp. of Mot. [Doc. No. 8-17].
¶64Deborah Gross Decl., Exs. M, N [Doc. Nos. 8-15, 8-16].
¶65In re Cendant Corp. Litig. , 264 F.3d at 267.
¶66Id. (citation omitted).
¶67Id. at 268.
¶68Trevena Group's joint declaration provides that Koch is a resident of Canada, Pierce is a resident of Connecticut, Beyers is a resident of Minnesota, Walsh is a resident of South Carolina, and Palmer is a resident of New Hampshire. Trevena Group Joint Decl. in Supp. of Mot. [Doc. No. 8-17] at 1-2.
¶69See, e.g. , In re Cendant Corp. Litig. , 264 F.3d at 270 ("Allegations of impropriety are not proof of wrongdoing. If they were, then any class member (or lawyer seeking to be appointed lead counsel) could disable any presumptive lead plaintiff by making unsupported allegations of impropriety.").
¶70Id. at 266.
¶71Id. at 266-67.
¶72SeeAguilar v. Vitamin Shoppe, Inc. , No. 17-6454, 2018 WL 1960444, at *10 (D.N.J. Apr. 25, 2018) (crediting that in their joint declaration submitted to the court, the group members explained that before deciding to file a joint motion, they thoroughly entertained such decision by conversing with one another); W. Palm Beach Police Pension Fund v. DFC Global Corp. , No. 13-6713, 2014 WL 1395059, at *8 (E.D. Pa. Apr. 10, 2014) ("[F]ocusing on the lack of a relationship between the members [of the group] is misplaced.... [T]he affidavits submitted ... show a willingness and ability to work together, discuss the issues surrounding the merits of this litigation, and decide on a procedural course of conducting this litigation."); cf.Takata v. Riot Blockchain, Inc. , Nos. 18-2293, 18-8031, 2018 WL 5801379, at *5 (D.N.J. Nov. 6, 2018) (holding that the lead plaintiff group was not adequate, in part because "[a]lthough they submitted a timely declaration, the declaration lacks any mention of contact prior to filing the motion"); Smith v. Suprema Specialties, Inc. , 206 F.Supp.2d 627, 637 (D.N.J. 2002) (holding that the group could not work effectively to adequately represent the interests of the class because the group "concede[d] that the only pre-existing relationship among the various proposed individuals [was] the fact that they all invested through the same broker").
¶73Trevena Group Joint Decl. in Supp. of Mot. [Doc. No. 8-17] at 2.
¶74Id. at 2-3. At the February 20 oral argument hearing, Trevena Group's counsel also informed the Court that the members have been closely following the case, have corresponded in a timely manner when necessary, and are more than adequately prepared to fairly and adequately protect the interests of the class.
¶75SeeIn re Petrobras Sec. Litig. , 104 F.Supp.3d 618, 622 (S.D.N.Y. 2015) (highlighting that proposed lead plaintiff groups must "demonstrate their ability to function as a cohesive and independent unit to protect the interests of the class").
¶76In re Cendant Corp. Litig. , 264 F.3d at 266. Because the presumptive status of Trevena Group has not been rebutted by the other Moving Plaintiffs, the Court need not address the merits of whether movant Lanphie Ping, with approximately half the amount of total losses as Trevena Group, would be a sufficient candidate for lead plaintiff.
¶78In re Cendant Corp. Litig. , 264 F.3d at 274 (internal quotation marks omitted).
¶79SeeIn re Cendant Corp. Litig. , 264 F.3d at 276 ("[T]he [PSLRA] evidences a strong presumption in favor of approving a properly-selected lead plaintiff's decisions as to counsel selection and counsel retention.").
¶80Deborah Gross Decl., Exs. M, N [Doc. Nos. 8-15, 8-16]; see alsoRabin , 254 F.Supp.3d at 761 ("Having reviewed movants' submissions to the Court, including the firm biographies, I find no basis to reject the presumption in favor of approving [lead plaintiff's] selection of counsel." (citation omitted)). As noted by Block & Leviton's publication, its experience in successful large class action securities litigation matters extend to plaintiffs in In re BP Sec. Litig. (S.D. Tex.), In re Google Inc. Class C S'holder Litig. (Del. Ch. Ct.), and In re Volkswagen "Clean Diesel" Mktg., Sales & Prods. Liab. Litig. (N.D. Cal.). Deborah Gross Decl., Ex. M [Doc. No. 8-15].